Advanced

Induction with anti-thymocyte globulin in heart transplantation is associated with better long-term survival compared with basiliximab.

Ansari, David LU ; Lund, Lars H; Stehlik, Josef; Andersson, Bodil LU ; Höglund, Peter LU ; Edwards, Leah and Nilsson, Johan LU (2015) In The Journal of Heart and Lung Transplantation 34(10). p.1283-1291
Abstract
The use of induction therapy may reduce the risk of acute rejection after heart transplantation. This study assessed the association between basiliximab (BAS) vs anti-thymocyte globulin (ATG) induction and long-term survival after heart transplantation.
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
The Journal of Heart and Lung Transplantation
volume
34
issue
10
pages
1283 - 1291
publisher
Elsevier
external identifiers
  • pmid:26087667
  • wos:000363095800007
  • scopus:84943348562
ISSN
1557-3117
DOI
10.1016/j.healun.2015.04.001
language
English
LU publication?
yes
id
9c878060-541a-4e93-8e99-39b645f5fbe6 (old id 7484916)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/26087667?dopt=Abstract
date added to LUP
2015-07-08 19:29:20
date last changed
2017-11-05 03:23:37
@article{9c878060-541a-4e93-8e99-39b645f5fbe6,
  abstract     = {The use of induction therapy may reduce the risk of acute rejection after heart transplantation. This study assessed the association between basiliximab (BAS) vs anti-thymocyte globulin (ATG) induction and long-term survival after heart transplantation.},
  author       = {Ansari, David and Lund, Lars H and Stehlik, Josef and Andersson, Bodil and Höglund, Peter and Edwards, Leah and Nilsson, Johan},
  issn         = {1557-3117},
  language     = {eng},
  number       = {10},
  pages        = {1283--1291},
  publisher    = {Elsevier},
  series       = {The Journal of Heart and Lung Transplantation},
  title        = {Induction with anti-thymocyte globulin in heart transplantation is associated with better long-term survival compared with basiliximab.},
  url          = {http://dx.doi.org/10.1016/j.healun.2015.04.001},
  volume       = {34},
  year         = {2015},
}